751470-47-0 Usage
General Description
Fmoc-L-cysteic acid is a derivative of the amino acid cysteine, commonly used in peptide and protein chemistry. It is composed of an Fmoc (fluorenylmethyloxycarbonyl) protecting group attached to the amino group of L-cysteic acid. This chemical compound is useful for the synthesis of peptide and protein molecules, as the Fmoc protecting group can be easily removed during solid-phase peptide synthesis. Fmoc-L-cysteic acid is also known for its ability to modify the properties of peptides and proteins, making it an important building block in the field of biochemistry and pharmaceutical research. Overall, Fmoc-L-cysteic acid serves as a valuable tool in the development and study of bioactive molecules.
Check Digit Verification of cas no
The CAS Registry Mumber 751470-47-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,5,1,4,7 and 0 respectively; the second part has 2 digits, 4 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 751470-47:
(8*7)+(7*5)+(6*1)+(5*4)+(4*7)+(3*0)+(2*4)+(1*7)=160
160 % 10 = 0
So 751470-47-0 is a valid CAS Registry Number.
751470-47-0Relevant articles and documents
A trimethyllysine-containing trityl tag for solubilizing hydrophobic peptides
Masuda, Shun,Tsuda, Shugo,Yoshiya, Taku
, p. 10228 - 10236 (2019)
Hydrophobic membrane peptides/proteins having low water solubility are often difficult to prepare. To overcome this issue, temporal introduction of solubilizing tags has been demonstrated to be beneficial. Following our recent work on the solubilization of a difficult target by using a hydrophilic oligo-Lys tag bearing a trityl linker (Trt-K method), this paper describes a comparative study of the solubilizing abilities of several peptidic trityl tags containing Lys, Arg, Glu, Asn, N?-tri-Me-Lys or Cys-sulfonate using two hydrophobic model peptides. Among the tags evaluated, that containing N?-tri-Me-Lys exhibits superior solubilizing ability.
DELIVERY SYSTEMS FOR CONTROLLED DRUG RELEASE
-
Paragraph 0419; 0422, (2019/01/15)
The present invention provides a compound having the structure of Formula (I) or a pharmaceutically acceptable salt, hydrate, solvate, or isomer thereof, for the controlled delivery and release of Agent.
